BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 28363605)

  • 1. Genetic or pharmacological depletion of cannabinoid CB1 receptor protects against dopaminergic neurotoxicity induced by methamphetamine in mice.
    Dang DK; Shin EJ; Mai AT; Jang CG; Nah SY; Jeong JH; Ledent C; Yamamoto T; Nabeshima T; Onaivi ES; Kim HC
    Free Radic Biol Med; 2017 Jul; 108():204-224. PubMed ID: 28363605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase Cδ mediates methamphetamine-induced dopaminergic neurotoxicity in mice via activation of microsomal epoxide hydrolase.
    Shin EJ; Jeong JH; Sharma G; Sharma N; Kim DJ; Pham DT; Trinh QD; Dang DK; Nah SY; Bing G; Kim HC
    Food Chem Toxicol; 2019 Nov; 133():110761. PubMed ID: 31422080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PKCδ-dependent p47phox activation mediates methamphetamine-induced dopaminergic neurotoxicity.
    Dang DK; Shin EJ; Kim DJ; Tran HQ; Jeong JH; Jang CG; Ottersen OP; Nah SY; Hong JS; Nabeshima T; Kim HC
    Free Radic Biol Med; 2018 Feb; 115():318-337. PubMed ID: 29269308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methiopropamine, a methamphetamine analogue, produces neurotoxicity via dopamine receptors.
    Nguyen PT; Dang DK; Tran HQ; Shin EJ; Jeong JH; Nah SY; Cho MC; Lee YS; Jang CG; Kim HC
    Chem Biol Interact; 2019 May; 305():134-147. PubMed ID: 30922767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PKCδ knockout mice are protected from para-methoxymethamphetamine-induced mitochondrial stress and associated neurotoxicity in the striatum of mice.
    Shin EJ; Dang DK; Tran HQ; Nam Y; Jeong JH; Lee YH; Park KT; Lee YS; Jang CG; Hong JS; Nabeshima T; Kim HC
    Neurochem Int; 2016 Nov; 100():146-158. PubMed ID: 27623093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of oxidative stress in methamphetamine-induced dopaminergic toxicity mediated by protein kinase Cδ.
    Shin EJ; Duong CX; Nguyen XT; Li Z; Bing G; Bach JH; Park DH; Nakayama K; Ali SF; Kanthasamy AG; Cadet JL; Nabeshima T; Kim HC
    Behav Brain Res; 2012 Jun; 232(1):98-113. PubMed ID: 22512859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apocynin prevents mitochondrial burdens, microglial activation, and pro-apoptosis induced by a toxic dose of methamphetamine in the striatum of mice via inhibition of p47phox activation by ERK.
    Dang DK; Shin EJ; Nam Y; Ryoo S; Jeong JH; Jang CG; Nabeshima T; Hong JS; Kim HC
    J Neuroinflammation; 2016 Jan; 13():12. PubMed ID: 26780950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginsenoside Re protects methamphetamine-induced dopaminergic neurotoxicity in mice via upregulation of dynorphin-mediated κ-opioid receptor and downregulation of substance P-mediated neurokinin 1 receptor.
    Dang DK; Shin EJ; Kim DJ; Tran HQ; Jeong JH; Jang CG; Nah SY; Jeong JH; Byun JK; Ko SK; Bing G; Hong JS; Kim HC
    J Neuroinflammation; 2018 Feb; 15(1):52. PubMed ID: 29467000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein Kinase Cδ Gene Depletion Protects Against Methamphetamine-Induced Impairments in Recognition Memory and ERK
    Tran TV; Shin EJ; Nguyen LTT; Lee Y; Kim DJ; Jeong JH; Jang CG; Nah SY; Toriumi K; Nabeshima T; Yamada K; Kim HC
    Mol Neurobiol; 2018 May; 55(5):4136-4159. PubMed ID: 28597397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal melatonin rescues methamphetamine-elicited mitochondrial burdens, pro-apoptosis, and dopaminergic degeneration through the inhibition PKCδ gene.
    Nguyen XK; Lee J; Shin EJ; Dang DK; Jeong JH; Nguyen TT; Nam Y; Cho HJ; Lee JC; Park DH; Jang CG; Hong JS; Nabeshima T; Kim HC
    J Pineal Res; 2015 Jan; 58(1):86-106. PubMed ID: 25407782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of protein kinase (PK) Cδ attenuates methamphetamine-induced dopaminergic toxicity via upregulation of phosphorylation of tyrosine hydroxylase at Ser40 by modulation of protein phosphatase 2A and PKA.
    Dang DK; Duong CX; Nam Y; Shin EJ; Lim YK; Jeong JH; Jang CG; Nah SY; Nabeshima T; Kim HC
    Clin Exp Pharmacol Physiol; 2015 Feb; 42(2):192-201. PubMed ID: 25400014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase Cδ mediates trimethyltin-induced neurotoxicity in mice in vivo via inhibition of glutathione defense mechanism.
    Shin EJ; Nam Y; Tu TH; Lim YK; Wie MB; Kim DJ; Jeong JH; Kim HC
    Arch Toxicol; 2016 Apr; 90(4):937-53. PubMed ID: 25895139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
    Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
    Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CB1 receptor is required for the establishment of the hyperlocomotor phenotype in developmentally-induced hypothyroidism in mice.
    Giné E; Echeverry-Alzate V; Lopez-Moreno JA; Rodriguez de Fonseca F; Perez-Castillo A; Santos A
    Neuropharmacology; 2017 Apr; 116():132-141. PubMed ID: 28017790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of system Xc
    Dang DK; Shin EJ; Tran HQ; Kim DJ; Jeong JH; Jang CG; Nah SY; Sato H; Nabeshima T; Yoneda Y; Kim HC
    Neurochem Int; 2017 Sep; 108():254-265. PubMed ID: 28457879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid CB1 receptors activation and coactivation with D2 receptors modulate GABAergic neurotransmission in the globus pallidus and increase motor asymmetry.
    Muñoz-Arenas G; Paz-Bermúdez F; Báez-Cordero A; Caballero-Florán R; González-Hernández B; Florán B; Limón ID
    Synapse; 2015 Mar; 69(3):103-14. PubMed ID: 25522178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of Dopamine Receptor 2 Long Affects Cannabinoid Receptor 1 Signaling in a Cell Culture Model of Striatal Medium Spiny Projection Neurons.
    Bagher AM; Laprairie RB; Kelly ME; Denovan-Wright EM
    Mol Pharmacol; 2016 Jun; 89(6):652-66. PubMed ID: 27053685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors.
    Martín AB; Fernandez-Espejo E; Ferrer B; Gorriti MA; Bilbao A; Navarro M; Rodriguez de Fonseca F; Moratalla R
    Neuropsychopharmacology; 2008 Jun; 33(7):1667-79. PubMed ID: 17957223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of dopamine D1 receptor in 3-fluoromethamphetamine-induced neurotoxicity in mice.
    Nguyen PT; Shin EJ; Dang DK; Tran HQ; Jang CG; Jeong JH; Lee YJ; Lee HJ; Lee YS; Yamada K; Nabeshima T; Kim HC
    Neurochem Int; 2018 Feb; 113():69-84. PubMed ID: 29197543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CB1 receptor antagonism increases hippocampal acetylcholine release: site and mechanism of action.
    Degroot A; Köfalvi A; Wade MR; Davis RJ; Rodrigues RJ; Rebola N; Cunha RA; Nomikos GG
    Mol Pharmacol; 2006 Oct; 70(4):1236-45. PubMed ID: 16855179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.